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Abstract
Lipid rafts have been shown to play an important role for G-protein mediated signal transduction and the
function of ligand-gated ion channels including their modulation by psychopharmacological compounds. In this
study, we investigated the functional signiﬁcance of the membrane distribution of NMDA and GABAA receptor
subunits in relation to the accumulation of the tricyclic antidepressant desipramine (DMI) and the benzo-
diazepine diazepam (Diaz). In the presence of Triton X-100, which allowed proper separation of the lipid raft
marker proteins caveolin-1 and ﬂotillin-1 from the transferrin receptor, all receptor subunits were shifted to the
non-raft fractions. In contrast, under detergent-free conditions, NMDA and GABAA receptor subunits were
detected both in raft and non-raft fractions. Diaz was enriched in non-raft fractions without Triton X-100 in
contrast to DMI, which preferentially accumulated in lipid rafts. Impairment of lipid raft integrity by methyl-b-
cyclodextrine (MbCD)-induced cholesterol depletion did not change the inhibitory eﬀect of DMI at the NMDA
receptor, whereas it enhanced the potentiating eﬀect of Diaz at the GABAA receptor at non-saturating con-
centrations of GABA. These results support the hypothesis that the interaction of benzodiazepines with the
GABAA receptor likely occurs outside of lipid rafts while the antidepressant DMI acts on ionotropic receptors
both within and outside these membrane microdomains.
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Introduction
Lipid rafts are distinct microdomains within the cell
membrane which are enriched in cholesterol and glyco-
sphingolipids (Pike, 2004). These heterogeneous and
dynamic structures ﬂoat within the membrane bilayer al-
lowing lipids and proteins to move in and out of these
membrane microdomains (Kusumi and Suzuki, 2005).
The concept of lipid rafts has attracted considerable in-
terest because these structures may aﬀect membrane traf-
ﬁcking and signal transduction processes (Tsiu-Pierchala
et al., 2002 ; Patel et al., 2008).
There is increasing evidence that lipid raft association
can also inﬂuence neurotransmitter receptor function by
aﬀecting transmitter binding, receptor traﬃcking and
clustering (Allen et al., 2007). In post-mortem brain tissue
of patients with major depression, G-protein subunit
(Gs)awas more likely associated with lipid rafts, where it
turned out to be less likely coupled to adenylyl cyclase
(Donati et al., 2008). Moreover, Gsa-mediated signalling
was enhanced by chronic treatment with antidepressants,
which prevented the accumulation of Gsa in lipid rafts
(Donati and Rasenick, 2005). With regard to ligand-gated
ion channels, the serotonin (5-HT)3A receptor has been
detected in raft-like domains (Eisensamer et al., 2005).
Likewise the GABAA receptor subunit a1 has been
reported to be lipid raft associated (Dalskov et al., 2005),
whereas a diﬀerential distribution of synaptic and extra-
synaptic GABAA receptor subunits has recently been
demonstrated (Li et al., 2007). Also the localization of
NMDA receptors within the cell membrane appears to
depend on the respective subunit composition (Hering
et al., 2003; Guirland et al., 2004).
A variety of antidepressants and antipsychotics
accumulate in raft-like domains, which exert their
functional antagonistic eﬀects at the 5-HT3 receptor
(Eisensamer et al., 2003, 2005 ; Rammes et al., 2004). More
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recently, we showed that 5-HT3 receptor function
depends on lipid raft integrity, whereas the ability of
antidepressants to modulate this receptor is retained after
lipid raft impairment (Nothdurfter et al., 2010).
So far, no data are available on the signiﬁcance of
lipid rafts for the modulation of NMDA and GABAA
receptors – crucial members of the most abundant excit-
atory and inhibitory neurotransmitter systems in the
central nervous system – by antidepressants and benzo-
diazepines. We therefore investigated the eﬀect of lipid
raft integrity on the allosteric modulation of GABAA
receptor function by diazepam (Diaz) and on the modu-
lation of NMDA receptor function by the tricyclic anti-
depressant desipramine (DMI). Moreover, the membrane
domain distribution of the receptor subunits and com-
pounds was investigated using diﬀerent conditions of li-
pid raft isolating procedures.
Method and materials
Chemicals and drugs
For stock solutions DMI (10 mM; Sigma-Aldrich,
Germany) was dissolved in H2O and Diaz (5 mM; Sigma-
Aldrich) in 80% ethanol.
Cell cultures
HEK 293 cells (European Collection of Cell Cultures, UK),
WSS-1 cells (ATCC LGC Promochem, Germany) and
HEK 293 cells stably expressing the human NMDA
receptor NR1A/2A, (NMDA-HEK; Merck, Germany),
were cultured in Dulbecco’s modiﬁed eagle medium
(Invitrogen, Germany) supplemented with 10% foetal
calf serum (FCS), 1% sodium pyruvate and antibiotics.
Cells were reseeded onto fresh Petri dishes twice weekly
after treatment with 1% trypsin-EDTA (Invitrogen). Cells
were cultured at 37 xC, 5% CO2 and 95% humidity.
Primary hippocampal neurons were obtained from rat
embryos (E20–E21) and were transferred to Ca2+- and
Mg2+-free Hank’s-buﬀered salt solution (Invitrogen).
Cells were dissociated in 0.66% trypsin/0.1% DNAse
following 0.05% DNAse/0.3% ovomucoid incubation.
After centrifugation, cells were resuspended in MEM
(Invitrogen) and plated on poly-DL ornithine/laminin
coated Petri dishes. Cells were cultured in NaHCO3/
Hepes-buﬀered MEM supplemented with 5% FCS and
5% horse serum. Glial mitosis was inhibited by cytosine-
b-D-arabinofuranoside.
Electrophysiological recordings
Voltage clamp recordings were made in the whole-cell
conﬁguration at a holding potential of x70 mV. Com-
pounds were applied using a fast superfusion device
with a stepper motor-driven (Warner Instruments LLC,
USA) application pipette, made from modiﬁed double-
barrelled theta glass. This arrangement allows complete
exchange of solutions superfusing all receptors expressed
on the cell surface within milliseconds. Currents were
recorded using an EPC-9 ampliﬁer (HEKA, Germany).
Patch clamp pipettes were pulled from borosilicate glass
using a horizontal puller (P-97 Puller ; Sutter Instruments,
USA), with resistances of 3–6 MV when ﬁlled with in-
tracellular solution. Intracellular solution for NMDA-
HEK: 120 mM CsCl ; 10 mM EGTA; 1 mM MgCl2 ; 0.2 mM
CaCl2 ; 10 mM glucose ; 22 mM TEACl ; 2 mM ATP; 0.2 mM
cAMP; pH 7.35. Corresponding extracellular bath sol-
ution: 140 mM NaCl; 3 mM KCl ; 10 mM glucose ; 10 mM
Hepes, 0.2 mM CaCl2 ; 4.5 mM sucrose ; pH 7.35. D-Serine
(5 mM) was present in all solutions suﬃcient to cause
80–85% activation of glycine B receptors. Intracellular
solution for GABAA receptor mediated currents from
WSS-1 cells : 140 mM KCl; 11 mM EGTA; 10 mM Hepes-
KOH; 2 mMMgCl2 ; 0.1 mM ATP; pH 7.35. Corresponding
extracellular bath solution : 162 mM NaCl ; 5.3 mM KCl ;
0.67 mM NaH2PO4 ; 0.22 mM KH2PO4 ; 5.6 mM glucose ;
15 mM Hepes ; 2 mM CaCl2 ; pH 7.4. Antagonism of
NMDA receptor-mediated currents was measured in
terms of the magnitude of the steady-state blocked cur-
rent as percentage of the control current. Five cumula-
tively increasing concentrations of the respective
compound were applied in the continuous presence of
agonists and the control current for each substance
concentration was calculated by a linear projection from
the steady-state current before and after substance ap-
plication, i.e. for the ﬁrst concentration control current=
0.85rcurrent before antagonist plus 0.15rrecovery cur-
rent. For the second substance concentration, these same
currents were multiplied by 0.7 and 0.3 respectively and
so on. The potency of the compound was assessed by
plotting the mean percentage current magnitude against
the antagonist concentration and then a curve was ﬁt
using the logistic equation for which the variable para-
meters IC50 and Hill coeﬃcient were free and the range
and background values were normally set to 100 and 0,
respectively. For analysis of GABA-induced currents in
WSS-1 cells only results of stable cells showing at least
50% recovery of responses to GABA following the re-
moval of drugs entered the ﬁnal analysis. To compensate
for this eﬀect the % antagonism at each concentration
was based on both the control and the recovery current
by assuming a linear time-course for the rundown.
Sucrose density gradient centrifugation
Two conﬂuent Petri dishes of cultured cells were washed
in ice-cold PBS before resuspension in 800 ml high-salt
Hepes buﬀer (20 mM Hepes, 5 mM EDTA, 1 M NaCl,
pH 7.4) supplemented with protease-inhibitor cocktail.
For solubilization 1% Triton X-100 was added directly to
the saline buﬀer as described previously (Nothdurfter
et al., 2007). Following homogenization and soniﬁcation,
the suspensionwas diluted 1:1 with 80% sucrose solution
prepared in high-salt Hepes buﬀer. The solution was then
1362 C. Nothdurfter et al.
 by guest on Septem
ber 13, 2016
http://ijnp.oxfordjournals.org/
D
ow
nloaded from
 
placed at the bottom of a centrifuge tube (Beckman
Coulter, USA) and overlaid with 1400 ml 35% sucrose and
ﬁnally with 1000 ml 5% sucrose (both prepared in low-salt
Hepes buﬀer : 20 mM Hepes ; 5 mM EDTA; 0.5 M NaCl ;
pH 7.4). Samples were ultracentrifuged at 40 000 rpm
(2 10 000 g) in a Beckman SW60 rotor for 4 h at 4 xC.
Subsequently, 10 fractions (400 ml each) were taken from
the top to the bottom of the gradient.
The experimental protocols for mouse brain tissue
fractionation were approved by the Ethical Committee
on Animal Care and Use of the Government of Bavaria,
Germany. Brains of male C57Bl6 mice aged 28–42 d
were put into ice-cold artiﬁcial cerebrospinal ﬂuid;
sagittal slices of the medial prefrontal cortex (350 mM)
were prepared using a microtome (HM 650 V; Microm
International, Germany). Tissue of one animal was
homogenized/soniﬁed in 1 ml high-salt Hepes buﬀer
supplemented with protease-inhibitor cocktail. The
suspension was centrifuged at 1000 g, 10 min, 4 xC. The
supernatant was again centrifuged at 8000 g, 10 min,
4 xC. For solubilization the supernatant of the second
centrifugation step was supplemented with 0.4%
Triton X-100 and incubated for 30 min on ice. The sol-
ution (1850 ml) was then diluted 1:1 with 80% sucrose,
overlaid with 3200 ml 35% sucrose and 2300 ml 5%
sucrose. After ultracentrifugation in an SW41 rotor at
40 000 rpm (2 50 000 g) for 4 h at 4 xC, 13 fractions (710 ml
each) were collected.
Cholesterol depletion
Cholesterol depletion using low doses of methyl-b-
cyclodextrine (MbCD) to maintain cell viability for elec-
trophysiological recordings was performed as described
previously (Nothdurfter et al., 2010). Brieﬂy, cells were
incubated with 0.25 or 0.5 mM MbCD for 12 h at 37 xC
in serum-free DMEM prior to the electrophysiological
recordings.
Western blotting
Equal volumes of sucrose gradient fractions were ad-
justed 1:5 with Laemmli sample buﬀer. For the detection
of GABAA receptor subunit c2, samples were heated at
70 xC, 10 min; all other samples were denaturated at
95 xC, 5 min. SDS-PAGE was performed on 12% gels.
After transfer to a nitrocellulose membrane and blocking
(TBS-T/5% milk powder), blots were probed with spe-
ciﬁc antibodies : transferrin receptor (mouse monoclonal,
Zymed, USA, dilution 1:1000) ; caveolin-1 (mouse
monoclonal, BD Biosciences, USA, dilution 1:3000) ;
ﬂotillin-1 (mouse monoclonal, BD Biosciences, dilution
1:1000) ; GABAA receptor subunit a1 (goat polyclonal,
Santa Cruz Biotechnologies, USA, dilution 1:500) ;
GABAA receptor subunit b2 (rabbit polyclonal,
Phosphosolutions, Germany, dilution 1:200) ; GABAA
receptor subunit c2 (Centre of Brain Research of the
University of Vienna, Austria, dilution 1:1000) ; NMDA
receptor subunit NR1A (goat polyclonal, Santa Cruz
Biotechnologies, dilution 1:300). After incubation with
horseradish peroxidase-coupled secondary antibodies,
speciﬁc antibody binding was visualized by ECL chemi-
luminescence (Amersham Biosciences, Germany).
Quantiﬁcation of DMI and Diaz
For the quantiﬁcation of DMI, 250 ml sucrose gradient
fractions, 750 ml H2O, 0.1 ml internal standard solution
and 1 ml 2 M sodium hydrogen carbonate buﬀer (adjusted
to pH 10.5) were mixed and supplemented with 5 ml
n-hexane/1.5% isoamyl-alcohol. After centrifugation
(4000 g, 15 min), the organic layer was transferred to a
tube containing 0.25 ml 0.18 M phosphoric acid, mixed
and centrifuged at 4000 g for 10 min. The organic layer
was discarded and an aliquot of the aqueous phase was
injected for chromatographic separation. For HPLC
analysis, a Beckman Coulter (USA) 166 variable-wave-
length UV detector and a Beckman Coulter gradient
pump 126 Solvent Module equipped with a Beckman
Coulter autoinjector 508 autosampler were used.
Separations were made on four coupled Chromolith per-
formance RP-18e 100r4.6 mm columns (Merck KGa A).
The mobile phases (A, 0.22% orthophosphoric acid ad-
justed to pH 3.5 ; B, acetonitrile) were degassed in an
ultrasonic bath immediately before use. The column
temperature was 30 xC, the ﬂow of the mobile phase was
1.5 ml/min. A mobile phase gradient was used for the
chromatographic analysis. DMI was determined by UV
absorption 214 nm wavelength. Samples were calibrated
using spiked samples at diﬀerent concentrations. The
quantiﬁcation was performed by calculating the internal
standard peak:area ratio of the analyte and a regression
model was ﬁtted to the peak:area ratio of the compound
to internal standard vs. concentration.
Diaz concentrations were measured using
liquid chromatography/mass spectrometry/mass spec-
trometry, which consisted of an Agilent 1100 HPLC sys-
tem (Agilent technologies, Germany) and an API 4000
triple quadrupole mass spectrometer (Applied Bio-
systems, Germany) equipped with a turbo ion spray
ionization interface in positive MRM mode. Chromato-
graphic separation was performed on a GEMINI C 18,
50 mmr2.0 mm (Phenomenex, USA) with particle size
5 mM. The mobile phase consisted of methanol-H2O
(85:15, v/v) containing 0.1% formic acid and 10 mM am-
monium formate. Isocratic separation was performed
with a ﬂow rate of 0.2 ml/min and a run time of
4 min. Column oven temperature was adjusted to 40 xC.
Protriptyline was selected as the internal standard.
The column eﬄuent was monitored at the following
transitions : Diaz m/z 285.1p154.0 and the internal
standard protriptyline 264.3p155.1. Diaz was extracted
with a modiﬁed liquid/liquid extraction procedure
with acetonitrile.
GABAA and NMDA receptor function and lipid rafts 1363
 by guest on Septem
ber 13, 2016
http://ijnp.oxfordjournals.org/
D
ow
nloaded from
 
Lowry protein assay
Protein concentration was determined by a modiﬁed
method of Lowry et al. (1951).
Cholesterol assay
Cholesterol concentrations were determined color-
imetrically with a commercial assay kit (Boehringer,
Germany).
Statistical analysis
Diﬀerences in electrophysiological parameters were
compared using t tests for paired samples. As a nominal
level of signiﬁcance, a=0.05 was accepted.
Results
Isolation of lipid rafts
In view of the controversial discussion about lipid raft
association of proteins in relation to the use of detergents,
we analysed the membrane distribution of the lipid raft
marker proteins ﬂotillin-1/caveolin-1 and the transferrin
receptor, a bona ﬁde non-raft protein, in the absence and
presence of detergent. HEK 293 cells (Fig. 1a) and mouse
neocortex (Fig. 1b) were fractionated by sucrose gradient
density centrifugation. In the absence of detergent
ﬂotillin-1 and caveolin-1 as well as the transferrin recep-
tor were detected both in low buoyant density (LBD) and
in high buoyant density (HBD) fractions of sucrose gra-
dients of HEK 293 cells and mouse neocortex. In contrast,
the addition of Triton X-100 shifted the transferrin
receptor to the HBD fractions, whereas ﬂotillin-1 and
caveolin-1 were retained in the LBD fractions, but lost
in the HBD fractions. With regard to the distribution of
cholesterol within the cell membrane, cholesterol con-
centrations were enriched predominantly in the LBD
fractions of mouse neocortex (Fig. 1c, upper panel).
Interestingly, the use of detergent did not aﬀect the
cholesterol distribution within membrane factions
(Fig. 1c, lower panel). Thus, methodological issues such
as the use of detergent are crucial for the designation
of proteins to be raft-associated or not, while cholesterol
distribution in the respective membrane fractions re-
mains unaﬀected. Consequently, we studied the mem-
brane distribution of ionotropic receptor subunits and
psychopharmacological compounds both under deter-
gent-free and detergent-containing conditions in the fol-
lowing experiments.
Eﬀect of lipid raft integrity for NMDA receptor
modulation by DMI
The antidepressant DMI reduced NMDA-induced
cation currents through human NMDA receptor subunits
NR1A/2A in a dose-dependent fashion with an IC50
value of 2.7¡0.3 mM (Fig. 2a, b). The control NMDA
currents and NMDA currents in the presence of diﬀerent
concentrations of DMI reached steady-state after ap-
proximately 5 s, thereby assuring correct current analysis
after receptor desensitization has been accomplished.
To investigate the membrane localization of the
NMDA receptor, we fractionated NMDA-HEK cells by
sucrose gradient density centrifugation and probed the
respective fractions with an antibody against the NMDA
receptor subunit NR1A (Fig. 2c). When no detergent
was used, immunoreactivity was detected both in the
low buoyant density fractions (LBD, at the top of the
gradient) and in the high buoyant density fractions (HBD,
at the bottom of the gradient). The use of Triton X-100
completely shifted the NMDA receptor subunit NR1A
to the HBD fractions. To aﬀect lipid raft integrity, we
partially depleted cholesterol from cell membranes by
means of low-dose MbCD treatment thereby retaining
cell viability for subsequent electrophysiological record-
ings as described previously (Nothdurfter et al., 2010).
Pre-treatment of primary hippocampal neurons with
0.1 mM MbCD for 12 h did not alter the inhibitory eﬀect
of DMI on NMDA/D-serine-evoked cation currents
(Fig. 2d, e).
55 55
55
without
detergent
without
detergent
+ Triton X-100
+ Triton X-100
+ Triton X-100
bottom
bottom bottom
flotillin-1
flotillin-1
Fraction number
caveolin-1
caveolin-1
transferrin R
transferrin R
flotillin-1
caveolin-1
transferrin R
flotillin-1
caveolin-1
transferrin R
top
Ch
ol
es
te
ro
l
(µ
g/
m
l)
without
detergent bottomtop
top top
22 22
22
95 95
95
300
250
200
150
100
50
0
1 2 3 4 5 6 7 8 9 10111213
Fraction number
Ch
ol
es
te
ro
l
(µ
g/
m
l)
250
200
150
100
50
0
1 2 3 4 5 6 7 8 9 10111213
55
22
95
(a)
(c)
(b)
Fig. 1. Eﬀect of detergent on the separation of ﬂotillin-1/
caveolin-1 from the transferrin receptor and cholesterol
distribution. HEK 293 cells (a) and mouse brain neocortex
(b) were homogenized, sonicated in high-salt buﬀer and
fractionated by sucrose gradient density centrifugation.
Fractions were collected and analysed by SDS-PAGE. Replicate
gels were immunoblotted with antibodies against ﬂotillin-1,
caveolin-1 and the transferrin receptor (transferrin R). One part
of HEK 293 cells or mouse neocortical tissue was prepared
without detergent, the other part was solubilized with Triton
X-100. (c) Sucrose gradient fractions of mouse neocortical
tissue were assayed for cholesterol concentrations. One part
of the tissue was prepared without detergent, the other part
was solubilized with Triton X-100. Results represent the
means¡S.E.M. of three independent experiments.
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Membrane distribution of desipramine and
diazepam and colocalization with the NMDA and
GABAA receptor
To determine whether the addition of detergent also
aﬀects the diﬀerential accumulation of psychopharma-
cological compounds, we quantiﬁed the concentrations
of DMI in sucrose gradient fractions of HEK 293 cells
after incubation with 10 mM DMI. As shown previously
(Eisensamer et al., 2005), DMI was enriched in the LBD
fractions using a detergent-free preparation procedure.
However, the addition of Triton X-100 caused a shift of
DMI to the HBD fractions (Fig. 3). Thus, the membrane
distribution of both proteins and antidepressive com-
pounds appears to be sensitive to the use of detergent.
Considering the antagonistic eﬀects of DMI at the
NMDA receptor we investigated whether the GABAA
receptor is also sensitive to modulation by DMI. Com-
pared to NMDA-induced currents, GABAA receptor-
mediated currents of WSS-1 cells were only slightly
inhibited by DMI even at high concentrations, which are
far above those achieved under clinical conditions
(Glotzbach and Preskorn, 1982; Fig. 4a). Following ap-
plication of 30 mM DMI, chloride currents were reduced
only to 73.0¡5.2% of control (charge of currents ex-
pressed as the area under the curve in relation to the
charge obtained in the absence of DMI, which is set as
100%). With a reduction to 86.6¡9.8%, the peak of re-
ceptor currents was even less aﬀected. To investigate
whether this rather moderate modulatory potency of
DMI at the GABAA receptor is related to a divergent
distribution of the compound and receptor subunits
within the cell membrane, we studied the membrane
localization of GABAA receptor subunits in WSS-1 cells
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Fig. 2. Inhibitory eﬀect of desipramine (DMI) on NMDA-evoked
cation currents and membrane distribution of the NMDA
receptor subunit NR1A. (a) Cation currents of HEK 293 cells
stably expressing NR1/NR2A composed NMDA receptors
(NMDA-HEK) were recorded in a whole-cell voltage-clamp
conﬁguration. Currents were recorded under a continuous
stimulation with 200 mM NMDA in the presence of 10 mM
glycine. Cells were exposed to increasing concentrations of
DMI (10 to 100 mM). The panel shows representative NR1/2A
receptor currents. The upper bar indicates increasing
concentrations of DMI; the lower bar indicates the presence
of NMDA/glycine. (b) Dose–response relationship of DMI
against the current amplitude. Results are expressed in % of
the control NMDA-induced currents obtained without DMI
and represent the means¡S.E.M. of ﬁve independent
experiments. (c) Membrane fractions of NMDA-HEK cells were
prepared by means of sucrose gradient density centrifugation
and were analysed by SDS-PAGE. Replicate gels were
immunoblotted with a polyclonal antibody against the NMDA
receptor subunit NR1. One part of the cells was prepared
without detergent, the other part was solubilized with Triton
X-100. LBD, low buoyant density fractions ; HBD, high buoyant
density fractions. (d) Cation currents of primary hippocampal
neurons were recorded in a whole-cell voltage-clamp
conﬁguration. 200 mM NMDA/5 mM D-serine was applied for
2 s in the absence or presence of 3 mM DMI. One portion of
cells was pre-treated with 0.1 mM methyl-b-cyclodextrine
(MbCD) for 12 h prior to the recordings (lower panel), the
other portion of cells remained untreated (control ; upper
panel). The upper bar indicates the presence of NMDA/
D-serine, the lower bar indicates the presence of DMI. One
representative recording is shown, respectively. (e) Peak
amplitude and plateau of untreated cells and after pre-
treatment with 0.1 mM MbCD for 12 h of seven independent
experiments are shown in the presence of 3 mM DMI in relation
to values in the absence of DMI, which are set as 100%
(control). Data are shown as means¡S.E.M. % of control. t Tests
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Fig. 3 Accumulation of desipramine (DMI) in membrane
fractions of HEK 293 cells in the presence of detergent (Triton
X-100). HEK 293 cells were incubated with 10 mM DMI for
30 min at 37 xC. After homogenization and soniﬁcation cells
were fractionated by sucrose gradient density centrifugation.
Fractions were collected and the concentrations of DMI were
determined by HPLC. Results are expressed as speciﬁc
concentration of DMI (ng DMI/mg protein). Data are
means¡S.E.M. of three independent experiments of homogenates
solubilized with Triton X-100. Under detergent-free conditions,
DMI was preferentially enriched in the low buoyant density
fractions (data not shown; Eisensamer et al., 2005).
for paired samples revealed no statistically signiﬁcant
diﬀerences between peaks and plateaus of untreated and
MbCD pretreated cells.
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(a1 and c2) and mouse neocortex (a1, b2 and c2 ; Fig. 4c).
Similarly to the NMDA receptor, all GABAA receptor
subunits were detected both in LBD and HBD fractions of
cells and tissue using a detergent-free protocol, but only
in the HBD fractions when using Triton X-100. Thus, the
membrane distribution of GABAA receptor subunits does
not explain the considerably weaker eﬀect of DMI at this
ligand-gated ion channel. Interestingly, the inhibitory
potency of DMI on GABAA receptor-mediated currents
appeared to be partially reversed under cholesterol-
depleting conditions (charge : 61.5¡5.0% untreated vs.
75.5¡10.7% MbCD pre-treated ; peak: 79.2¡5.6% un-
treated vs. 97.5¡3.4% MbCD pre-treated; Fig. 4b).
Benzodiazepines are potent positive allosteric mod-
ulators of GABAA receptors. We therefore investigated
the modulatory properties of Diaz on GABAA receptor
function in relation to the membrane distribution of
GABAA receptor subunits and that of Diaz. As shown
previously (Davies et al., 2000), 1 mM Diaz markedly po-
tentiated GABA-evoked chloride currents of WSS-1 cells
(235.7¡15.2%; charge of the currents expressed as the
area under the curve in relation to the charge obtained in
the absence of Diaz, which is set as 100%; data represent
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Fig. 4. Eﬀect of desipramine (DMI) on GABA-evoked chloride
currents and membrane distribution of GABAA receptor
subunits. (a) 30 mM DMI was applied to WSS-1 cells containing
recombinant a1c2 and low levels of endogenous b3 GABAA
receptor subunits. Chloride currents were recorded in a whole-
cell voltage-clamp conﬁguration under conditions of a 500 ms
stimulation with 100 mM GABA. The upper panel shows a
representative original recording. The upper bar indicates the
presence of GABA; the lower bar indicates the presence of
DMI. The lower panel shows peak amplitude and charge
expressed as the area under the curve (AUC) of the GABA-
evoked currents in relation to values obtained in the absence of
DMI, which is set as 100% (% of control). Data are presented as
the means¡S.E.M. of ten independent experiments. For
calculation of the ﬁnal DMI eﬀect, values from control and
recovery traces were included into the analysis. (b) 30 mM DMI
was applied to WSS-1 cells in serum-free medium (untreated)
and after cholesterol depletion induced by 0.5 mM methyl-b-
cyclodextrine (MbCD). Chloride currents were recorded in a
whole-cell voltage-clamp conﬁguration under conditions of a
500 ms stimulation with 100 mM GABA. The upper panel shows
representative original recordings. The upper bar indicates the
presence of GABA; the lower bar indicates the presence of
DMI. The lower panel shows peak amplitude and charge
expressed as the AUC of the GABA-evoked currents in relation
to values obtained in the absence of DMI, which is set as 100%
(% of control). Data are presented as the means¡S.E.M. of ﬁve
independent experiments, respectively. For calculation of the
ﬁnal DMI eﬀect, values from control and recovery traces were
included into the analysis. T tests for paired samples revealed a
statistically signiﬁcant diﬀerence between peaks of untreated
and MbCD pre-treated cells ; * p<0.05. (c) WSS-1 cells and
mouse neocortical tissue were homogenized, sonicated and
fractionated by sucrose gradient density centrifugation either
in the presence or absence of detergent. Fractions of the
gradient were collected and analysed by SDS-PAGE. Replicate
gels were immunoblotted with antibodies against the GABAA
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Fig. 5. Potentiation of GABA-evoked chloride currents by
diazepam (Diaz) and membrane distribution of Diaz. (a) Diaz
(1 mM) was applied to WSS-1 cells containing a1b3c2 GABAA
receptor subunits. Chloride currents were recorded in a
whole-cell voltage-clamp conﬁguration under conditions of 5 s
stimulation with 10 mM GABA. A representative original
recording is shown. The upper bar indicates the presence of
GABA; the lower bar indicates the presence of Diaz. (b) HEK 293
cells (upper panel) or mouse brain neocortex (lower panel) were
incubated with 1 mM Diaz for 30 min at 37 xC. After
homogenization and soniﬁcation cells and tissue were
fractionated by sucrose gradient density centrifugation in the
absence of detergent. Fractions were collected and analysed for
the concentrations of Diaz by mass spectrometry. Results are
expressed as speciﬁc concentration of Diaz (ng Diaz/mg
protein). Data are expressed as means¡S.E.M. of three
independent experiments.
receptor subunits a1, b2 (for mouse neocortex) and c2. The
expression of the b3 subunit in WSS-1 cells was below the limit
of detection by Western blotting.
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the means¡S.E.M. of ﬁve independent experiments ; Fig.
5a). This potentiating eﬀect was antagonised by 10 mM
ﬂumazenil (data not shown). The distribution of Diaz
within the cell membrane was determined in sucrose
gradient fractions of HEK 293 cells and mouse neocortex
after incubation with 1 mM Diaz (Fig. 5b). In contrast to
DMI, which was enriched in the LBD fractions, Diaz
preferentially accumulated in the HBD non-raft fractions
already under detergent-free conditions. This distri-
bution pattern was not altered when Triton X-100 was
used for preparation of lipid rafts (data not shown). Thus,
both ligand-gated ion channel subunits and psycho-
pharmacological compounds show diﬀerent distribution
patterns within the cell membrane with regard to lipid
raft association.
Eﬀect of lipid raft integrity for GABAA receptor
modulation by Diaz
Impairment of lipid raft integrity by pre-treatment
of WSS-1 cells with MbCD for 12 h dose-dependently
diminished GABA-evoked chloride currents (Fig. 6a–c).
The shift of the GABA dose–response curve to the
right after MbCD treatment (Fig. 6d) indicates reduced
agonist eﬀectiveness when receptors are not integrated in
lipid rafts. When receptors were activated at submaximal
GABA concentrations (Fig. 6e) the GABA enhancing
eﬀect of Diaz i.e. increase in GABA potency was even
more pronounced under MbCD pre-treatment condi-
tions. However, the maximal Diaz-induced potentiation
of receptor currents did not change (Fig. 6 f), i.e. maximal
currents observed with saturating concentrations of
GABA were the same both in the presence and absence
of Diaz.
Because cholesterol depletion decreased membrane
stability and deteriorated patch-clamp recording con-
ditions the generation of a concentration–response curve
in the presence of Diaz was not achievable with 0.5 mM
MbCD. However, leak current and membrane resistance
of HEK cells after treatment with 0.5 mM MbCD were
comparable to those cells that were untreated. Pre-
treatment with 0.25 mM MbCD reduced membrane chol-
esterol content to 82.10% of control (data not shown).
Consequently, this concentration did not result in a suf-
ﬁcient shift to the right of the GABA concentration–
response curve as observed at 0.5 mM MbCD. These
results indicate that substantial amounts of GABAA re-
ceptors were still incorporated into lipid rafts.
Discussion
In the present study we investigated the membrane dis-
tribution of NMDA and GABAA receptor subunits in
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Fig. 6 Eﬀect of methyl-b-cyclodextrine (MbCD) induced
cholesterol depletion of WSS-1 cells on GABA-evoked chloride
currents and their modulation by diazepam (Diaz). (a)
Potentiating eﬀect of Diaz at the GABAA receptor of WSS-1 cells.
Chloride currents were recorded in a whole-cell voltage-clamp
conﬁguration. 30 mM GABA were applied for 500 ms in the
absence or presence of 1 mM Diaz. The upper bars indicate the
presence of GABA, the lower bar indicates the presence of
Diaz. Representative recordings before and after application
of Diaz and subsequent washout are shown. Potentiating eﬀect
of Diaz at the GABAA receptor of WSS-1 cells after cholesterol
depletion induced by 0.25 mM MbCD (b) or 0.5 mM MbCD (c).
Chloride currents were recorded in a whole-cell voltage-clamp
conﬁguration. GABA (30 mM) were applied for 500 ms in the
absence or presence of 1 mM Diaz. The upper bars indicate the
presence of GABA, the lower bar indicates the presence of Diaz.
Representative recordings before and after application of Diaz
and subsequent washout are shown. Cells were treated with
0.25/0.5 mM MbCD for 12 h prior to the recordings. (d)
Dose–response relationship of the GABA-evoked current charge
through the GABAA receptor of untreated WSS-1 cells and of
WSS-1 cells pre-treated with 0.5 mM MbCD. Results are
normalized to the maximum receptor current induced by 3 mM
GABA and presented as means¡S.E.M. of seven independent
experiments. (e) Charges of untreated cells and after
pre-treatment with 0.5 mM MbCD for 12 h evoked by 30 mM
GABA (left panel) or 100 mM GABA (right panel) in the presence
of 1 mM Diaz of ﬁve independent experiments in relation to
values in the absence of Diaz, which are set as 100% (control).
Data are shown as means¡S.E.M. % of control (currents evoked
with 30 or 100 mM GABA). Statistically signiﬁcant diﬀerences
between charges of untreated and MbCD pre-treated cells (t test
for paired samples, * p<0.05). (f) Dose–response relationship of
the GABA-evoked current charge through the GABAA receptor
of untreated WSS-1 cells and of WSS-1 cells pre-treated with
0.25 mM MbCD. Results are normalized to the maximum
receptor current induced by 3 mM GABA and presented as
means¡S.E.M. of ﬁve independent experiments. Also presented
are means¡S.E.M. of normalized charges of untreatedWSS-1 cells
treated with 1 mM Diaz of four independent experiments and
means¡S.E.M. of normalized charges of WSS-1 cells pre-treated
with 0.25 mM MbCD treated with 1 mM Diaz of four independent
experiments. nH, Hill coeﬃcient.
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relation to their allosteric modulation by DMI and Diaz.
The assignment of receptor subunits and drugs to speciﬁc
membrane fractions turned out to be strongly dependent
on the preparation procedure. A partial colocalization of
receptor subunits and the compounds within the cell
membrane was found under detergent-free conditions
and a complete overlap in non-raft fractions when using
detergent (Fig. 7). Impairment of lipid raft integrity by
cholesterol depletion did not substantially alter the
modulatory potency of DMI at the NMDA and GABAA
receptor. However, impairment of lipid raft integrity af-
fected the positive allosteric modulation of the GABAA
receptor by benzodiazepines.
Preparation of lipid rafts heavily relies on the puriﬁ-
cation method employed. Commonly, lipid rafts are
considered as membrane fractions that are resistant to
non-ionic detergents such as Triton X-100 (Brown and
Rose, 1992). In fact, we found that the use of detergent
allowed proper separation of the lipid raft marker pro-
teins caveolin-1 and ﬂotillin-1 from the transferrin re-
ceptor, which is widely considered as a non-raft protein
(Nothdurfter et al., 2007). This is in line with previous
ﬁndings reporting a dose-dependent eﬀect of Triton
X-100 on the separation of raft from non-raft proteins
(Brady et al., 2004). On the other hand, the use of
detergent-free protocols has been suggested to more
closely reﬂect the physiological situation (Schnitzer et al.,
1995a, b ; Smart et al., 1995 ; Song et al., 1996; Luria et al.,
2002 ; Eisensamer et al., 2005 ; Persaud-Sawin et al., 2009).
Accordingly, diﬀerent compositions and properties of
lipid rafts have been reported depending on the extrac-
tion method used (Foster et al., 2003 ; Kim et al., 2004;
Sprenger and Horrevoets, 2007; Garner et al., 2008;
Pike, 2009). Consequently, we studied the membrane
distribution of ligand-gated ion channels and psycho-
pharmacological compounds under both detergent-free
and detergent-containing conditions in the present study.
The detergent-free protocol revealed a much more
diﬀerential distribution pattern of ionotropic receptor
subunits and compounds investigated, although the
separation of prototypical markers of raft and non-raft
proteins appeared more challenging.
Concerning the NMDA receptor, the NR1A subunit
has been located in non-raft membrane fractions of
rat forebrain when using an Optiprep gradient without
detergent solubilization (Wu et al., 1997). In a study by
Hering et al. (2003), NR1 was found both in raft and in
non-raft fractions under detergent-containing conditions.
A non raft-association has been reported for the NR1,
NR2A and NR2B subunits using Triton X-100 as a deter-
gent (Suzuki et al., 2001). Besshoh et al. (2007) found lipid
raft association of the NR2A subunit under detergent-
containing conditions, whereas the NR2B subunit in rat
brain tissue shifted from post-synaptic densities to lipid
rafts with increasing age. A study by Ponce et al. (2008)
suggested an important role of lipid raft integrity for
NMDA receptor function, showing that the reduction of
cholesterol levels by simvastatin might protect from
NMDA-induced neuronal damage by reducing the as-
sociation of the NR1 subunit with lipid rafts. In our study,
impairment of lipid raft integrity by cholesterol depletion
did not aﬀect the modulatory potency of DMI at the
NMDA receptor, which suggests that the membrane lo-
calization of this receptor and compound plays a minor
role for its modulation by this antidepressant. In some
contrast to the NMDA receptor, lipid raft impairment
partially reversed the antagonistic eﬀect of DMI at the
GABAA receptor, although this eﬀect appeared only
marginally. Detergent-free lipid raft preparation yielded
a clear distribution of both DMI and partially GABAA
receptor subunits in the raft fractions. Thus, cholesterol
depletion might interfere with the pharmacological
eﬀects of DMI on GABAA receptors by e.g. impairing
ligandrreceptor interaction, thereby weakening the
antagonistic potency.
With regard to lipid raft association of GABAA re-
ceptors, an almost exclusive lipid raft association has
been claimed for the a1 subunit of rat cerebellar granule
cells after puriﬁcation with the detergent Brij 98 (Dalskov
et al., 2005). Following multiple solubilization steps
with Triton X-100 of rat forebrain tissue, distinct GABAA
receptor subunit combinations have been attributed to
diﬀerent cell membrane compartments (Li et al., 2007).
The a and b subunits in the absence of c subunits, which
might represent extra-synaptic receptors, have been
detected in detergent-resistant membranes/lipid rafts. In
contrast, synaptic assemblies containing a and b subunits
together with the c2 subunit showed only negligible lipid
raft association.
Without detergent
NMDA (NR1A)
GABAA (α1, β2, γ2)
Diaz
DMI
HBD/non-raft
LBD/lipid raft
LBD/lipid raft
+ Triton X-100
NMDA
GABAA
Diaz
DMI
HBD/non-raft
Fig. 7. Schematic diagram showing the distribution of receptors
and compounds in lipid raft and non-raft membrane fractions
of sucrose gradients. Diaz, diazepam; DMI, desipramine ; LBD,
low buoyant density fractions ; HBD, high buoyant density
fractions.
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In our study, the use of the detergent Triton X-100
shifted NMDA and GABAA receptor subunits to the HBD
fractions of sucrose gradients. However, when using a
detergent-free protocol, a much more diﬀerential distri-
bution pattern of ionotropic receptors within the cell
membrane could be observed. NMDA receptor (NR1A
subunit) and GABAA receptor subunits (a1, b2, c2) were
distributed both over the LBD and the HBD fractions of
the sucrose gradient. In contrast, the 5-HT3 receptor was
located predominantly in the lipid raft-associated LBD
fractions (Eisensamer et al., 2005 ; Nothdurfter et al.,
2010). Presumably, physiological and pharmacological
processes are more reliably reﬂected using detergent-free
protocols.
Currently, only few data are available concerning
the distribution of psychopharmacological drugs within
membrane fractions. The tricyclic antidepressant DMI,
which modulates the 5-HT3 receptor in a non-competitive
manner (Eisensamer et al., 2003), was predominantly ac-
cumulated in raft-like domains and colocalized with the
5-HT3 receptor protein under detergent-free conditions
as shown previously for various other antidepressants
and antipsychotics (Eisensamer et al., 2005). However,
the addition of Triton-X-100 during preparation com-
pletely shifted DMI to the HBD fractions, but had no ef-
fect on the cholesterol distribution within the cell
membrane. These results are in contrast to the benzodia-
zepine Diaz, which was enriched in the HBD fractions
already under detergent-free conditions. Thus, in spite of
their common lipophilic properties, various psycho-
pharmacological compounds display a diﬀerential as-
sociation with lipid rafts, which might contribute to their
distinct psychopharmacological proﬁle.
It has been shown previously that the tricyclic anti-
depressant DMI acts as a functional antagonist at the
NMDA receptor (Sernagor et al., 1989 ; Watanabe et al.,
1993 ; Szasz et al., 2007). Our experiments performed with
NMDA receptors expressed in HEK cells conﬁrm these
results. Furthermore, currents showed a nearly complete
recovery to the control steady-state level after removal of
the antagonist. This observation and the fact that the
original cytosolic content is mainly dominated by the in-
tracellular pipette solution with no protein left, renders a
DMI-mediated mechanism via receptor internalisation
unlikely and rather speaks in favour of a direct antagon-
ism at the receptor. Although the concentrations required
for these modulatory eﬀects are in the low micromolar
range, they are nevertheless of clinical relevance in view
of a high brain : plasma ratio of tricyclic antidepressants
(Glotzbach and Preskorn, 1982). On the other hand, DMI
delivered at rather high concentrations only slightly af-
fected GABA-evoked chloride currents, thereby indicat-
ing that the eﬀect of DMI on GABAA receptors appears to
be less potent as compared to NMDA receptors and is not
of clinical relevance. Thus, the colocalization of DMI with
subunits of ionotropic receptors seems not to be suﬃcient
for a potent allosteric receptor modulation in general.
The benzodiazepine Diaz markedly potentiated
GABA-evoked chloride currents, which is in line with
previous studies (Davies et al., 2000). Diaz was coloca-
lized with GABAA receptor subunits in the HBD fractions
already under detergent-free conditions, which supports
the hypothesis that synaptic GABAA receptors, which are
sensitive to benzodiazepines, are located predominantly
within non-raft fractions (Li et al., 2007). To investigate the
role of the membrane localization of the GABAA receptor
for its modulation by benzodiazepines we impaired lipid
raft integrity by MbCD-induced cholesterol depletion.
MbCD treatment diminished GABAA receptors currents
per se, similarly to the results previously found for the
5-HT3 receptor (Nothdurfter et al., 2010). The potentiating
eﬀect of Diaz appeared to be enhanced at lower GABA
concentrations under cholesterol-depleting conditions.
However, due to technical limitations related to choles-
terol depletion, we could not perform Schild plot analysis
which would have provided deﬁnite clarity about the
eﬀects of benzodiazepines at the GABAA receptor under
conditions of cholesterol depletion. Nevertheless, our re-
sults suggest that, at submaximal GABA concentrations,
benzodiazepines show an increased eﬀectiveness at
GABAA receptors after cholesterol depletion. Together
with the preferential accumulation of Diaz in non-raft
fractions, these results argue for the hypothesis that the
interaction of benzodiazepines with the GABAA receptor
likely occurs outside lipid rafts.
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